Nicaragua
Diabetes country report 2011 — 2050
Number of adults (20–79 years) with diabetes in Nicaragua (NI)
2011 | 282.8 thousand |
2024 | 377.0 thousand |
2050 | 762.6 thousand |
Nicaragua is one of the 19 countries and territories in the IDF South and Central America Region.
Data source(s) used for the diabetes estimates in adults:
- CAMDI Report, Nicaragua,2010.
- Barcelo A et al. Diabetes Care. 2012 Apr;35(4):738-40. doi: 10.2337/dc11-1614. PMID:22323417
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | - | 282.8 | 377.0 | 762.6 |
Age-standardised prevalence of diabetes, % | - | 11.0 | 10.4 | 12.3 |
Proportion of people with undiagnosed diabetes, % | - | - | 44.6 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 168.2 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 317.0 | 570.0 |
Age-standardised prevalence of IFG, % | - | - | 8.0 | 9.1 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 324.7 | 408.0 | 738.4 |
Age-standardised prevalence of IGT, % | - | 11.3 | 10.3 | 11.7 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 2,774.0 | 1,854.5 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 8.6 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 221.3 | 349.8 |
Total diabetes-related health expenditure, ID million | - | - | 603.6 | 954.0 |
Diabetes-related health expenditure per person, USD | - | 174.0 | 587.0 | 458.7 |
Diabetes-related health expenditure per person, ID | - | - | 1,601.1 | 1,251.0 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 5,315.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 918.5 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | - | 3,163.3 | 4,352.8 | 6,364.1 |
Population of children and adolescents (0-19 y) | - | - | 2,640,713.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | - |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | - |
Population of children and adolescents (0-19 y) | - |